Jersey City-based Organon announced Sept. 18 it entered into an agreement to acquire Dermavant Sciences Ltd. in a $1.2 billion deal. The terms of the deal include an upfront payment of $175 million ...
Journey Medical (DERM): microcap biopharma with cash-generating dermatology portfolio and high-upside Emrosi launch. Read ...
VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional indication to treat atopic dermatitis Proposed ...
Company to hold conference call today at 4:30 p.m. ET to discuss the financial results and provide a business update SCOTTSDALE, Ariz., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation ...
Journey Medical Corporation misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.07. Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and ...
SAN FRANCISCO--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology, is participating in the 44 th J.P. Morgan Healthcare Conference 2026, taking ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results